[Evaluation of the effectiveness of the treatment of arteriosclerosis].
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy*; D001593:Benzyl Compounds / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D002784:Cholesterol / Q000097:blood; D002855:Chromatography, Thin Layer; D002994:Clofibrate / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D010713:Phosphatidylcholines / Q000097:blood; D010714:Phosphatidylethanolamines / Q000097:blood; D010743:Phospholipids / Q000097:blood; D011422:Propionates / Q000627:therapeutic use*; D013109:Sphingomyelins / Q000097:blood; D014280:Triglycerides / Q000097:blood
D001593:Benzyl Compounds; D006834:Hydrazines; D000960:Hypolipidemic Agents; D008055:Lipids; D008074:Lipoproteins; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D010743:Phospholipids; D011422:Propionates; D013109:Sphingomyelins; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate
K otsenke effektivnosti lecheniia ateroskleroza